SCHEMBL19986489

SCHEMBL19986489

O=CN1CCCN(c2c(Cl)cncc2Cl)CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.50
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HCAR2 Q8TDS4 1/20 0.41
RAB9A P51151 1/20 0.36
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
CCNC P24863 8/20 0.34
CDK8 P49336 8/20 0.34
CHRNA1 P02708 1/20 0.33
CHRNA7 P36544 1/20 0.33
ALDH1A3 P47895 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21599145 0.90 LMNA (0.42) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599176 0.84 LMNA (0.38) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599203 0.83 CYP3A4 (0.39) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL19986733 0.80 ADRB2 (0.67) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599148 0.80 BCL2A1 (0.44) CYP3A4MAPTALDH1A3
SCHEMBL21599151 0.77 CYP3A4 (0.43) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599195 0.77 ADRB2 (0.41) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599186 0.77 ADRB2 (0.50) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL21599143 0.76 ADRB2 (0.53) ADRB2LMNANPSR1KDM4ECYP3A4
SCHEMBL16707783 0.75 ADRB2 (0.49) ADRB2LMNANPSR1KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068774-B1 AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS NOVIRA THERAPEUTICS INC (US) 2019-12-25 EP disclosed
WO-2018050110-A1 NOVEL CAPSID PROTEIN ASSEMBLY INHIBITOR 正大天晴药业集团股份有限公司 2018-03-22 WO disclosed